Leili Gao

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Placebo Controlled

Top Venues

Diabetes, obesity & metabolism

Journal of diabetes

This page only lists publications with an associated author ORCID identifier.

Publications

Xiantong Zou, Leili Gao, Zhikai Feng, Guoliang Chen, Jing Fu, Erin Morgan, Sanjay Bhanot, Shan Gao, Hongyan Zhang, Zicai Liang, Li-Ming Gan
The efficacy and safety of ISIS 449884 injection as monotherapy in patients with type 2 diabetes: A randomized phase II study. Diabetes, obesity & metabolism (2024)
Li-Nong Ji, Jinmiao Lu, Leili Gao, Changjiang Ying, Jiao Sun, Jie Han, Wenhua Zhao, Yunming Gao, Kun Wang, Xin Zheng, Daosheng Xie, Juping Ding, Jiahong Zhao, Qiang Yu, Tong Wang
Efficacy and safety of cetagliptin as monotherapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled phase 3 trial. Diabetes, obesity & metabolism (2023)
Leili Gao, Xingwu Ran, Xuejun Liu, Xingping Shen, Shuchun Chen, Fuqiang Liu, Dong Zhao, Yan Bi, Qing Su, Yao Lu, Minxiang Lei, Yanfang Wang, Xiantong Zou
The effects of daily dose and treatment duration of metformin on the prevalence of vitamin B12 deficiency and peripheral neuropathy in Chinese patients with type 2 diabetes mellitus: A multicenter cross-sectional study. Journal of diabetes (2023)
Li-Nong Ji, Jinmiao Lu, Leili Gao, Xiaoguang Yan, Jifang Li, Zhifeng Cheng, Lili Zhang, Junhang Tian, Ping Li, Jie Bai, Daosheng Xie, Jiahong Zhao, Juping Ding, Qiang Yu, Tong Wang
A randomized, double-blind, placebo controlled, phase 3 trial to evaluate the efficacy and safety of cetagliptin added to ongoing metformin therapy in patients with uncontrolled type 2 diabetes with metformin monotherapy. Diabetes, obesity & metabolism (2023)
Leili Gao, Zhifeng Cheng, Benli Su, Xiuhai Su, Weihong Song, Yushan Guo, Lin Liao, Xiaowen Chen, Jiarui Li, Xingrong Tan, Fangjiang Xu, Shuguang Pang, Kun Wang, Jun Ye, Yuan Wang, Lili Chen, Jingfang Sun, Li-Nong Ji
Efficacy and Safety of Janagliflozin as Add-on Therapy to Metformin in Chinese Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Alone: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Trial. Diabetes, obesity & metabolism (2022)
Ying Du, Leili Gao, Xinhua Xiao, Xin Hou, Linong Ji
A multicentre, randomized, double-blind, parallel, active- and placebo-controlled Phase 3 clinical study of the glucokinase activator PB-201 in treatment-naive patients with type 2 diabetes mellitus: A study protocol. Diabetes, obesity & metabolism (2022)
Leili Gao, Puhong Zhang, Jian-Ping Weng, Juming Lu, Xiaohui Guo, Weiping Jia, Wenying Yang, Dajin Zou, Zhiguang Zhou, Changyu Pan, Yan Gao, Xian Li, Dongshan Zhu, Yangfeng Wu, Satish K Garg, Xiantong Zou
Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes: results from the Observational Registry of Basal Insulin Treatment (ORBIT). Journal of diabetes 12 (9) (2020)